Literature DB >> 23567081

Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence.

Christian Toso, Gilles Mentha, Pietro Majno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23567081     DOI： 10.1016/j.jhep.2013.03.029

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  9 in total

Review 1.  Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.

Authors:  Nicola de'Angelis; Filippo Landi; Maria Clotilde Carra; Daniel Azoulay
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 2.  Optimization of immunosuppressive medication upon liver transplantation against HCC recurrence.

Authors:  Shirin Elizabeth Khorsandi; Nigel Heaton
Journal:  Transl Gastroenterol Hepatol       Date:  2016-04-06

Review 3.  Hepatocellular Carcinoma and Liver Transplantation: State of the Art.

Authors:  Andrea Mancuso; Giovanni Perricone
Journal:  J Clin Transl Hepatol       Date:  2014-09-15

4.  Cutaneous Metastases from Primary Hepatobiliary Tumors as the First Sign of Tumor Recurrence following Liver Transplantation.

Authors:  Adam T Hauch; Joseph F Buell; Margit McGowan; Parisha Bhatia; Eleanor Lewin; Mary Killackey; Nathan J Shores; Luis A Balart; Martin Moehlen; Bob Saggi; Anil S Paramesh
Journal:  Case Rep Transplant       Date:  2014-07-10

5.  Impact of Tumour Biology on Outcomes of Radical Therapy for Hepatocellular Carcinoma Oligo-Recurrence after Liver Transplantation.

Authors:  Kin-Pan Au; James Yan-Yue Fung; Wing-Chiu Dai; Albert Chi-Yan Chan; Chung-Mau Lo; Kenneth Siu-Ho Chok
Journal:  J Clin Med       Date:  2022-07-28       Impact factor: 4.964

Review 6.  Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma.

Authors:  Carlo Sposito; Davide Citterio; Matteo Virdis; Carlo Battiston; Michele Droz Dit Busset; Maria Flores; Vincenzo Mazzaferro
Journal:  World J Gastroenterol       Date:  2022-09-14       Impact factor: 5.374

Review 7.  Potential use of multikinase inhibitors in immunosuppressed patients with malignancies including thyroid cancer.

Authors:  Neus Basté Rotllan
Journal:  Cancer Med       Date:  2022-10       Impact factor: 4.711

8.  Management of Adverse Events Associated with Cabozantinib Treatment in Patients with Advanced Hepatocellular Carcinoma.

Authors:  Gabriel Schwartz; Julianne O Darling; Malori Mindo; Lucia Damicis
Journal:  Target Oncol       Date:  2020-08       Impact factor: 4.493

9.  Seeding of hepatocellular carcinoma into the stomach wall following endoscopic ultrasound and fine-needle aspiration biopsy.

Authors:  M Kasi; Samin Rashid; S A J Wallace; Vijayendran Sujendran; Bill Griffiths; Andrew Butler; Paul Gibbs; Loveena Sreedharan; A M Zaitoun; S Venkatachalapathy; M W James; G P Aithal
Journal:  Oxf Med Case Reports       Date:  2018-07-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.